Psychological Predictors of Retention in a Low-Threshold Methadone Maintenance Treatment for Opioid Addicts: A 1-Year Follow-Up Study

REFERENCES

• Abramsohn, Y., Peles, E., Potik, D., Schreiber, S., & Adelson, M. (2009). Sense of coherence as a stable predictor for methadone maintenance treatment (MMT) outcome. Journal of Psychoactive Drugs, 41, 249–253.
   PubMed Web of Science ®Google Scholar
• Backmund, M., Meyer, K., Eichenlaub, D., & Schutz, C. G. (2001). Predictors for completing an inpatient detoxification program among intravenous heroin users, methadone substituted and codeine substituted patients. Drug and Alcohol Dependence, 64, 173–180.
   PubMed Web of Science ®Google Scholar
• Benninghoff, F., Gervasoni, J. P., Spencer, B., & Dubois-Arber, F. (1998). Characteristics of attenders of low threshold syringe-exchange centers providing sterile syringes in Switzerland. Revue d’épidémiologie et de santé publique, 46, 205–217.
   PubMedGoogle Scholar
• Bergeron, J., Landry, M., Ishak, A., Vaugeois, P., & Trépanier, M. (1992). Validation d'un instrument d’évaluation de la gravité des problèmes reliés à la consommation de drogues et alcool: l'Indice de gravité d'une toxicomanie (IGT). Montreal, Quebec: Rapport présenté à la Direction générale de la planification et de l’évaluation. Ministère de la Santé et des Services Sociaux, Gouvernement du Québec.
   Google Scholar
• Booth, R. E., Corsi, K. F., & Mikulich-Gilbertson, S. K. (2004). Factors associated with methadone maintenance treatment retention among street-recruited injection drug users. Drug and Alcohol Dependence, 74, 177–185.
   PubMed Web of Science ®Google Scholar
• Boyer, R., Preville, M., Legare, G., & Valois, P. (1993). Psychological distress in a noninstitutionalized population of Quebec: Normative results of the Quebec health survey. Canadian Journal of Psychiatry, 38, 339–343.
   PubMed Web of Science ®Google Scholar
• del Rio, M., Mino, A., & Perneger, T. V. (1997). Predictors of patient retention in a newly established methadone maintenance treatment programme. Addiction, 92, 1353–1360.
   PubMed Web of Science ®Google Scholar
• Fischer, B., Vasdev, S., Haydon, E., Baliunas, D., & Rehm, J. (2005). Willing to undergo hepatitis C treatment in a sample of injection drug users in Toronto, Canada. Research Support, Non-U.S. Gov't. Presse médicale, 34, 1209–1212.
   PubMed Web of Science ®Google Scholar
• Haug, N. A., Sorensen, J. L., Gruber, V. A., & Song, Y. S. (2005). Relapse prevention for opioid dependence. In G. A. Marlatt & D. M. Donovan (Eds.), Relapse prevention: Maintenance strategies in the treatment of addictive behaviours (2nd ed., pp. 151–178). New York, NY: Guilford Press.
   Google Scholar
• Health Canada. (2002). A report on mental illnesses in Canada. Ottawa, Canada: Health Canada Editorial Board Mental Illnesses in Canada. Retrieved from http://www.phac-aspc.gc.ca/publicat/miic-mmac/pdf/men_ill_e.pdf.
   Google Scholar
• Joe, G. W., Simpson, D. D., & Broome, K. M. (1998). Effects of readiness for drug abuse treatment on client retention and assessment of process. Addiction, 93, 1177–1190.
   PubMed Web of Science ®Google Scholar
• Jones, J. D., Mogali, S., & Comer, S. D. (2012). Polydrug abuse: A review of opioid and benzodiazepine combination use. Drug and Alcohol Dependence, 125, 8–18.
   PubMed Web of Science ®Google Scholar
• Magura, S., Nwakeze, P. C., & Demsky, S. Y. (1998). Pre- and in-treatment predictors of retention in methadone treatment using survival analysis. Addiction, 93, 51–60.
   PubMed Web of Science ®Google Scholar
• Mancino, M., Curran, G., Han, X., Allee, E., Humphreys, K., & Booth, B. M. (2010). Predictors of attrition from a national sample of methadone maintenance patients. American Journal of Drug and Alcohol Abuse, 36, 155–160.
   PubMed Web of Science ®Google Scholar
• Marsch, L. A., Stephens, M. A., Mudric, T., Strain, E. C., Bigelow, G. E., & Johnson, R. E. (2005). Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependence. Experimental and Clinical Psychopharmacology, 13, 293–302.
   PubMed Web of Science ®Google Scholar
• McLellan, A. T., Kushner, H., Metzger, D., Peters, R., Smith, I., Grissom, G.,…, Argeriou, M. (1992). The fifth edition of the addiction severity index. Journal of Substance Abuse Treatment, 9, 199–213.
   PubMed Web of Science ®Google Scholar
• National Institutes on Drug Abuse/National Institutes of Health/U.S. Dept of Health and Human Services Prescription and Over-the-Counter Medications. (2009) Retrieved on November 15, 2011 from: http://www.drugabuse.gov/PDF/ Infofacts/PainMed09.pdf
   Google Scholar
• Nosyk, B., Geller, J., Guh, D. P., Oviedo-Joekes, E., Brissette, S., Marsh, D. C.,…, Anis, A. H. (2010). The effect of motivational status on treatment outcome in the North American Opiate Medication Initiative (NAOMI) study. Drug and Alcohol Dependence, 111, 161–165.
   PubMed Web of Science ®Google Scholar
• Ogborne, A. C., & Birchmore-Timney, C. (1999). A framework for the evaluation of activities and programs with harm-reduction objectives. Substance Use & Misuse, 34, 69–82.
   PubMed Web of Science ®Google Scholar
• Peles, E., Linzy, S., Kreek, M., & Adelson, M. (2008). One-year and cumulative retention as predictors of success in methadone maintenance treatment: A comparison of two clinics in the United States and Israel. Journal of Addictive Diseases, 27, 11–25.
   PubMed Web of Science ®Google Scholar
• Perreault, M., Heroux, M. C., White, N. D., Lauzon, P., Mercier, C., & Rousseau, M. (2007). Treatment retention and evolution of clientele in a low threshold methadone substitution treatment program in Montreal. Canadian Journal of Public Health, 98, 33–36.
   PubMed Web of Science ®Google Scholar
• Perreault, M., Rousseau, M., Lauzon, P., Mercier, C., Tremblay, I., & Héroux, M. C. (2008). Determinants of retention in a Canadian low-threshold methadone maintenance program. Journal of Maintenance in the Addictions, 3, 37–51.
   Google Scholar
• Prochaska, J. O. (1995). An eclectic and integrative approach: Transtheoretical therapy. In A. S. Gurman & S. B. Messer (Eds.), Essential psychotherapies: Theory and practice (pp. 403–440). New York: The Guilford Press.
   Google Scholar
• Prochaska, J. O., & DiClemente, C. C. (1986). Toward a comprehensive model of change. In W. R. Miller & N. Heather (Eds.), Treating addictive behaviors: Processes of change (pp. 3–27). New York: Plenum Press.
   Google Scholar
• Riley, D. (1994). La réduction des méfaits liés aux drogues: Politique et pratiques [Decreasing drug-related damages: Politic and practices]. In P. Brisson(Ed.), L'usage des drogues et la toxicomanie [Drugs and drug-habit] vol. 2. Boucherville, Québec: Gaétan Morin.
   Google Scholar
• Rogers, S. J., & Ruefli, T. (2004). Does harm reduction programming make a difference in the lives of highly marginalized, at-risk drug users? Harm Reduction Journal, 1, 7.
   PubMedGoogle Scholar
• Rollnick, S., Heather, N., Gold, R., & Hall, W. (1992). Development of a short ‘readiness to change’ questionnaire for use in brief, opportunistic interventions among excessive drinkers. British Journal of Addiction, 87, 743–754.
   PubMedGoogle Scholar
• Rosenberg, M. (1965). Society and the adolescent self-image. Princeton, NY: Princeton University Press.
   Google Scholar
• Ryrie, I. W., Dickson, J., Robbins, C., Maclean, K., & Climpson, C. (1997). Evaluation of a low-threshold clinic for opiate-dependent drug users. Journal of Psychiatric and Mental Health Nursing, 4, 105–110.
   PubMedGoogle Scholar
• Santé Québec. (1988). Psychiatric symptoms index. Quebec: Les publications du Québec, ministère de la Santé et des Services sociaux.
   Google Scholar
• Sheerin, I., Green, T., Sellman, D., Adamson, S., & Deering, D. (2004). Reduction in crime by drug users on a methadone maintenance therapy programme in New Zealand. New Zealand Medical Journal, 117, U795-1–10.
   Google Scholar
• Simpson, D. D., & Joe, G. W. (1993). Motivation as a predictor of early dropout from drug abuse treatment. Psychotherapy, 30, 357–368.
   Web of Science ®Google Scholar
• Simpson, D. D., Joe, G. W., & Rowan-Szal, G. A. (1997). Drug abuse treatment retention and process effects on follow-up outcomes. Drug and Alcohol Dependence, 47, 227–235.
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration (SAMHSA). (2010). Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of National Findings (Office of Applied Studies, NSDUH Series H-38A, HHS Publication No SMA 10-4586 Findings). Rockville, MD: Substance Abuse and Mental Health Services Administration.
   Google Scholar
• Sutton, S. (2001). Back to the drawing board? A review of applications of the transtheoretical model to substance use. Addiction, 96, 175–186.
   PubMed Web of Science ®Google Scholar
• Torrens, M., Castillo, C., & Perez-Sola, V. (1996). Retention in a low-threshold methadone maintenance program. Drug Alcohol Depend, 41, 55–59.
   PubMed Web of Science ®Google Scholar
• Vallière, E. F., & Vallerand, R. J. (1990). Traduction et Validation Canadienne-Française de L’échelle de L'estime de Soi de Rosenberg. International Journal of Psychology, 25, 305–316.
   Google Scholar
• Veilleux, J. C., Colvin, P. J., Anderson, J., York, C., & Heinz, A. J. (2010). A review of opioid dependence treatment: Pharmacological and psychosocial interventions to treat opioid addiction. Clinical Psychological Review, 30, 155–166.
   PubMed Web of Science ®Google Scholar
• West, R. (2005). Time for a change: Putting the Transtheoretical (Stages of Change) Model to rest. Addiction, 100, 1036–1039.
   PubMed Web of Science ®Google Scholar